Document is current
Any future updates will be listed below
-
Authors
Aday, Jacob S.
Glynos, Nicolas G.
Baker, Anne K.
Pouyan, Niloufar
Smith, Tristin
Barron, Julie
Herberholz, Moss
Kruger, Daniel J.
Woolley, Joshua D.
Boehnke, Kevin F.
-
Funding
Funding for this research was provided by:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (T32AR007080-44S1)
- License Information
-
More Information
Article History
Received: 7 February 2025
Accepted: 6 April 2026
First Online: 15 April 2026
Declarations
:
: This research did not receive any specific grants from funding agencies in the public, commercial, or not-for-profit sectors. JSA’s effort on this publication was partially supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under T32AR007080-44S1. JB is the Founder/President of the Michigan Psychedelic Society, Co-Director of Decriminalize Nature Michigan, Board Member of Decriminalize Nature, Founder/Executive Director of Decriminalize Nature Ann Arbor, Psychedelic Integration and Music Therapist at Blue Sage Health Consulting, and Board Member of Michigan Dancesafe. JDW has been a paid consultant for Silo Pharma and Filament Health. KFB has received grant funding from Tryp Therapeutics for protocol development, and sits on a data safety and monitoring board for an ongoing clinical trial with Vireo Health (unpaid). No other author has conflicts of interest.
